Occudo Quantitative Strategies LP Cyma Bay Therapeutics, Inc. Transaction History

Occudo Quantitative Strategies LP

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 14, 2023	BUY	$7.47 - $10.95 $641,015 - $939,641	85,812 New	85,812 $939,000
Q1 2022 May 16, 2022	SELL	$2.77 - $3.64 $33,381 - $43,865	-12,051 Closed	0 $0
Q4 2021 Feb 14, 2022	SELL	$3.23 - $4.6 $120,553 - $171,685	-37,323 Reduced 75.59%	12,051 $41,000
Q3 2021 Nov 15, 2021	SELL	$3.47 - $4.42 $119,767 - $152,556	-34,515 Reduced 41.14%	49,374 $180,000
Q2 2021 Aug 16, 2021	SELL	$3.94 - $4.92 $138,849 - $173,385	-35,241 Reduced 29.58%	83,889 $366,000
Q1 2021 May 14, 2021	BUY	$4.23 - $6.55 $503,919 - $780,301	119,130 New	119,130 $541,000

1.82M

Ticker CBAY
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 84,677,904
Description
CymaBay Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing and providing therapies to treat liver and other chronic diseases. Its lead product candidate is seladelpar (MBX-8025), a selective agonist of peroxisome proliferator activated receptor delta that is in phase III clinical study for the treatments of pri...

Get notified when there are updates to the investment portfolio of Occudo Quantitative Strategies LP, based on Form 13F filings with the SEC.

Stay updated on Occudo Quantitative Strategies LP with notifications on news.